Skip to main content

Peer Review reports

From: A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial

Original Submission
23 Jul 2023 Submitted Original manuscript
12 Aug 2023 Reviewed Reviewer Report - Matthias Briel
22 Aug 2023 Author responded Author comments - Flavia Lucia Lombardo
Resubmission - Version 2
22 Aug 2023 Submitted Manuscript version 2
22 Aug 2023 Editorially accepted
5 Dec 2023 Article published 10.1186/s13063-023-07638-w

You can find further information about peer review here.

Back to article page